Dudum said individuals are taking greater control of care through DTC access, preventive health, and wider use of AI. ・BofA ...

The stock boasts the one year return of 34.3%, in contrast to 16.4% for the S&P 500. This situation necessitates a ...

Hims & Hers Health is significantly undervalued, with the market underestimating its growth potential and international ...

This post is brought to you in paid partnership with Hims. We’re one week into the new year. By now, the initial burst of ...

Investing.com -- Hims & Hers Health (NYSE:HIMS) stock fell 4% Friday after Amazon (NASDAQ:AMZN) Pharmacy announced it would ...

A coalition of telehealth providers from Amazon and Hims & Hers to hospital systems is working to extend pandemic-era waivers ...

Hims & Hers Health, Inc. analysis: subscription health platform growth, GLP-1 risks, and catalysts in women’s health & ...

Hims & Hers Health (NYSE: HIMS) went public in January 2021 through a SPAC merger, positioning itself as a multi-specialty ...

A short squeeze occurs when a stock's price rises unexpectedly, forcing short sellers (who are now losing money) to ...

The ad that Hims & Hers Health plans to air during the Super Bowl comes at you with rapid-fire visual overload—a giant jiggling belly, bare feet on scales, X-ray results, sugary sodas, a pie in the ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Shares in Hims & Hers Health, Inc. (NYSE: HIMS) are skyrocketing in early-morning trading today after the telehealth company announced a new partnership with the Danish pharmaceutical giant Novo ...